Effectiveness and safety of Dupilumab for the treatment at 104 weeks of recalcitrant bullous pemphigoid.

Manzo Margiotta, Flavia; Fidanzi, Cristian; Bevilacqua, Matteo; Janowska, Agata; Romanelli, Marco; Manni, Elisabetta

Effectiveness and safety of Dupilumab for the treatment at 104 weeks of recalcitrant bullous pemphigoid.

Manzo Margiotta, Flavia; Fidanzi, Cristian; Bevilacqua, Matteo; Janowska, Agata; Romanelli, Marco; Manni, Elisabetta.

Affiliation

Manzo Margiotta F; Department of Dermatology, University of Pisa, Pisa, Italy.
Fidanzi C; Department of Dermatology, University of Pisa, Pisa, Italy.
Bevilacqua M; Department of Dermatology, University of Pisa, Pisa, Italy.
Janowska A; Department of Dermatology, University of Pisa, Pisa, Italy.
Romanelli M; Department of Dermatology, University of Pisa, Pisa, Italy.
Manni E; Department of Dermatology, University of Pisa, Pisa, Italy.

Skin Res Technol ; 29(10): e13488, 2023 10.

Article in En | MEDLINE | ID: mdl-37881049

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pemphigoid, Bullous Limits: Humans Language: En Journal: Skin Res Technol Journal subject: DERMATOLOGIA Year: 2023 Document type: Article Affiliation country: Italia Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google